Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis

Abstract

MMF is very well tolerated and appears to be at least as effective as the other current therapies for dcSSc. Our results provide support for further evaluation of MMF in a prospective trial.